Bukwang Pharmaceutical Co., Ltd. (003000.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 312.7B |
| Enterprise Value | 296.83B |
| P/E Ratio | 46.13 |
| PEG Ratio | -1.56 |
| Price/Sales Ratio | 1.78 |
| Price/Book Ratio | 1.17 |
| Enterprise/Revenue | 1.68 |
| Enterprise/EBITDA | 23.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 200.71B |
| Revenue/Share | 2,149.06 |
| Gross Profit | 95.72B |
| EBITDA | 19.65B |
| Net Income | 12.57B |
| Diluted EPS | 152 |
Balance Sheet
| Total Cash | 169.1B |
| Total Cash/Share | 1,689.49 |
| Total Debt | 80.67B |
| Total Debt/Equity | 0.24 |
| Current Ratio | 2.33 |
| Book Value Per Share | 3,341.01 |
Price History
| 52-Week Change | 9.27 |
| 52-Week High | 9,890 |
| 52-Week Low | 3,510 |
| Moving Average 50 Days | 4,096 |
| Moving Average 200 Days | 4,897.3 |
Statistics
| Average Volume | 441,250 |
| Shares Outstanding | 98.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 125 |
| Trailing Annual Dividend Yield | 3.21 |
| Payout Ratio | 0.84 |
| Last Split Factor | 11:10 |
| Last Split Date | December 29, 2020 |
AD
